HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Siegfried G Priglinger Selected Research

Disease Progression

10/2023PORES OF THE INTERNAL LIMITING MEMBRANE: A Common Finding in Vitreomaculopathies.
8/2021The neuroprotective role of Wnt signaling in the retina.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Siegfried G Priglinger Research Topics

Disease

13Macular Degeneration (Age-Related Maculopathy)
01/2024 - 11/2002
13Retinal Perforations
10/2023 - 01/2006
12Proliferative Vitreoretinopathy
01/2023 - 01/2003
12Epiretinal Membrane (Epiretinal Membranes)
03/2022 - 08/2004
11Macular Edema
11/2022 - 10/2003
8Retinal Detachment (Retinal Detachments)
06/2023 - 09/2006
8Cataract (Cataracts)
01/2023 - 12/2007
6Capsule Opacification
03/2021 - 07/2007
4Neoplasms (Cancer)
02/2023 - 01/2020
4Melanoma (Melanoma, Malignant)
02/2023 - 08/2019
4Fibrosis (Cirrhosis)
09/2018 - 10/2005
4Cicatrix (Scar)
07/2007 - 01/2004
3Astigmatism
01/2024 - 05/2022
3Neoplasm Metastasis (Metastasis)
02/2023 - 01/2022
3Retinal Vein Occlusion
11/2022 - 10/2007
3Choroidal Neovascularization
01/2022 - 05/2020
3Glaucoma
09/2020 - 09/2006
3Diabetic Retinopathy (Retinopathy, Diabetic)
02/2008 - 10/2003
2Gliosis
10/2023 - 01/2020
2Disease Progression
10/2023 - 08/2021
2Ischemia
11/2022 - 11/2007
2Central Serous Chorioretinopathy
11/2021 - 05/2020
2Atrophy
01/2021 - 01/2020
2Presbyopia
01/2020 - 05/2018
1Allergic Conjunctivitis (Giant Papillary Conjunctivitis)
02/2024
1Hypersensitivity (Allergy)
02/2024
1Keratoconjunctivitis
02/2024
1Atopic Dermatitis (Atopic Eczema)
02/2024
1Retinal Dystrophies
08/2023
1Endophthalmitis (Ophthalmia)
04/2023
1Channelopathies
01/2023
1Photophobia (Light Sensitivity)
12/2022
1Vascular Diseases (Vascular Disease)
11/2022
1Rupture
01/2022
1Uveal melanoma
01/2022
1Aneurysm (Aneurysms)
01/2022
1Infections
12/2021
1Retinal Diseases
08/2021
1Geographic Atrophy
01/2021
1Color Vision Defects (Color Blindness)
01/2021

Drug/Important Bio-Agent (IBA)

14Retinaldehyde (Retinal)IBA
08/2023 - 10/2003
8Retinal Pigments (Pigments, Visual)IBA
01/2016 - 11/2002
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 06/2019
5Proteins (Proteins, Gene)FDA Link
01/2021 - 07/2005
4Capsules (Microcapsules)IBA
09/2022 - 09/2005
4Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2022 - 01/2006
4Coloring Agents (Dyes)IBA
01/2022 - 09/2005
4Fibronectins (Fibronectin)IBA
03/2011 - 03/2004
3Fluorescein (Funduscein)FDA LinkGeneric
11/2022 - 02/2008
3Messenger RNA (mRNA)IBA
01/2020 - 09/2006
3CollagenIBA
03/2018 - 01/2004
3Trypan BlueFDA Link
04/2013 - 08/2004
3Bromphenol Blue (Bromophenol Blue)IBA
05/2009 - 12/2007
2dupilumabIBA
02/2024 - 02/2024
2Biomarkers (Surrogate Marker)IBA
11/2022 - 01/2020
2trametinibIBA
01/2022 - 08/2019
2CateninsIBA
08/2021 - 01/2020
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2020 - 09/2006
2Ranibizumab (Lucentis)FDA Link
01/2018 - 01/2015
2microplasminIBA
12/2017 - 11/2017
2Bevacizumab (Avastin)FDA Link
11/2007 - 10/2007
2TransglutaminasesIBA
11/2006 - 07/2005
2epsilon-(gamma-glutamyl)-lysineIBA
09/2006 - 07/2005
1Omalizumab (Xolair)FDA Link
02/2024
1Immunoglobulin E (IgE)IBA
02/2024
1Immunologic Factors (Immunomodulators)IBA
02/2024
1Ophthalmic Solutions (Eye Drops)IBA
02/2024
1Interleukin-4 Receptors (Interleukin 4 Receptor)IBA
02/2024
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2023
1Silicone OilsIBA
09/2022
1Epidermal Growth Factor (EGF)IBA
01/2022
1EverolimusFDA Link
01/2022
1AZD 6244IBA
01/2022
1erucylphospho- N,N,N- trimethylpropylammoniumIBA
01/2022
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2022
1fluocinoloneIBA
01/2022
1ErbB Receptors (EGF Receptor)IBA
03/2021
1Gefitinib (Iressa)FDA Link
03/2021
1Spironolactone (Aldactone)FDA LinkGeneric
01/2021
1AntigensIBA
11/2020

Therapy/Procedure

18Vitrectomy
10/2023 - 09/2006
11Lasers (Laser)
11/2022 - 10/2003
10Therapeutics
08/2023 - 01/2018
9Traction
10/2023 - 06/2011
8Intraocular Lenses (Intraocular Lens)
01/2023 - 01/2012
4Intravitreal Injections
12/2017 - 10/2007
3Phacoemulsification
01/2023 - 06/2018
3Laser In Situ Keratomileusis (LASIK)
09/2019 - 07/2005
2Refractive Surgical Procedures
01/2024 - 05/2018
2Aftercare (After-Treatment)
02/2023 - 01/2022
2Brachytherapy
01/2022 - 11/2021
2Vitreoretinal Surgery
01/2020 - 10/2005
2Injections
01/2018 - 10/2007
1Off-Label Use
02/2024
1Transplantation
06/2023
1Salvage Therapy
02/2023
1Critical Care (Surgical Intensive Care)
12/2021
1Laser Therapy (Surgery, Laser)
11/2021
1Proton Therapy
11/2021
1Radiotherapy
01/2021